US could scrub the plaque off Alzheimer’s in months
The country is set to fast-track a ‘breakthrough’ drug that could stop disease in those with early dementia
The first drug that could halt Alzheimer’s disease is to be fast-tracked for approval, in what experts say could be the biggest breakthrough yet.
Charities said the decision by US watchdogs to give the treatment a “priority review” could mean it would be prescribed within six months, giving hope to sufferers everywhere. Trials have found that patients given aducanumab showed improvements in their language skills and ability to keep track of time and place. Memory loss was also slower.
Currently, medicines prescribed for Alzheimer’s only mask the symptoms. But the new treatment, which works by helping to untangle clumps of plaque in the brain, could be the first to halt disease progression, trials suggested...